Jeffrey M. Johnston
Keine laufenden Positionen mehr
Profil
Jeffrey M.
Johnston worked as Vice President-Clinical Research at Triangle Pharmaceuticals, Inc. and as Chief Medical Officer & VP-Drug Development at Critical Therapeutics, Inc. He then worked as Chief Medical Officer & VP-Clinical Development at Ironwood Pharmaceuticals, Inc. from 2005 to 2016.
After that, he worked as Chief Medical Officer & Senior Vice President at Ra Pharmaceuticals, Inc. and as Principal at GSK Plc.
Johnston received his undergraduate degree from Davidson College and his doctorate from Duke University School of Medicine.
Ehemalige bekannte Positionen von Jeffrey M. Johnston
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| RA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| GSK PLC | Corporate Officer/Principal | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Critical Therapeutics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jeffrey M. Johnston
| Davidson College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
